Direktorat Registrasi ObatValid

FONKOZOMIB

BPOM Number: DKL1641500344A1
Approved: 8 August 2025
Expiry: 1 August 2030
Form: SERBUK INJEKSI LIOFILISASI

About This Registration

FONKOZOMIB is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKL1641500344A1. Its current registration status is Valid, with the licence valid until 1 August 2030. The product is registered to FONKO INTERNATIONAL PHARMACEUTICALS - INDONESIA. BPOM first approved this registration in August 2025. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: newaero
Packaging: DUS, 1 VIAL @ 3,5 MG
Department: Direktorat Registrasi Obat
Data Last Updated: 13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

FONKO INTERNATIONAL PHARMACEUTICALS - INDONESIA
KAB. BEKASI
NPWP: 312735350413000
owner
View profile →

Manufacturing Sites

FONKO INTERNATIONAL PHARMACEUTICALS - INDONESIA
KAB. BEKASI
primary
View profile →

Ingredients (1)

BORTEZOMIB

Market Intelligence

Owner Portfolio: FONKO INTERNATIONAL PHARMACEUTICALS - INDONESIA holds 17 BPOM registrations
Manufacturer Scale: FONKO INTERNATIONAL PHARMACEUTICALS - INDONESIA produces 17 registered products
Registration Age: Registered for 11 months

Is this your product?